Answer
Tepmetko can cause foetal harm during pregnancy, based on its mechanism of action and animal findings of teratogenicity; there are no clinical data in pregnant women, and it should not be used unless the woman’s clinical condition requires tepotinib treatment.
Sources for this answer
- TEPMETKO 225 mg film-coated tabletsMerck · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked